Sunday, December 6, 2015

EXPERIMENT 5 : CONTENT OF IBUPROFEN (ASSAY)


Title 
Content of ibuprofen (assay)

Objective 
To calculate the content of ibuprofen

Apparatus 
Filter funnel , Filter paper , Beaker , Retort stand , Conical flask , Dryer , Burette , Weighing boat

Materials 
20 tablet of ibuprofen
Ethanol
Phenophthalein
0.1M sodium hydroxide


Procedure :
1.      20 Ibuprofen tablets previously selected at random is weighed and powdered.
2.      A quantity of powder containing 0.5 g ibuprofen is extracted with 20 ml chloroform for 15 minutes and is filtered through a sintered glass crucible ( BS Porosity No. 1)
3.      The residue is washed 3 times with 10ml chloroform and the combined filtrate is gently evaporated just to dryness in a current of air. The residue is dissolved in 100ml with ethanol (96%) previously neutralized to phenolphthalein solution.
4.      The solution is titrated with 0.1M sodium hydroxide to end point with phenolphthalein solution as the indicator . The content of ibuprofen is calculated if each ml of 0.1M sodium hydroxide is equivalent to 0.02063g of C13H18O2.






Result and calculation

The weight of 20 tablets Ibuprofen in powder form                          = 7.94g
Active ingredient of ibuprofen in each tablet                                    = 0.5g
Active ingredient of ibuprofen in 20 tablets                                     = 4.0 g

500 mg / 4000 mg  = Y / 7940 mg
Y = 992.5 mg
Titration of 0.1M sodium hydroxide = 15 ml

0.1M sodium hydroxide is equal to 0.02063 g of Ibuprofen
15 ml x 0.02063 g = 0.30945 g
Percentage of deviation : [ (0.5 – 0.30945) x 100 ] ÷ 0.5 = 38.11 %

Discussion

            The amount of active ingredient in each Ibuprofen tablet is 0.5g which is expected  to be the final mass. However, the calculated value is different from theoretical value which is 38.11 % deviation ( 0.30945 g). The volume of NaOh of titration process is expected to be aroun 24 mL for 0.5 g of Ibuprofen.
            This may be due to some errors occurred during the experiment.The solution are not filtered properly using filter funnel and filter paper which then cause some of the powder that are not dissolved in the chloroform will pass through into the conical flask. In addition to that, the tablets used might be already expired.  So, the physicochemical properties of Ibuprofen tablets might be affected.

Conclusion
            In conclusion, the content of Ibuprofen from the experiment is 0.30945 g which is slightly different with theory, 0.5 g due to some errors.


References
1.         https://en.wikipedia.org/wiki/Ibuprofen
2.         Introduction to Pharmaceutical Analysis, By Steen Hansen, Stig Pedersen-Bjergaard, Knut Rasmussen
(https://books.google.com.my/books?id=S7S6a4OYTasC&lpg=PP1&pg=PP1#v=onepage&q&f=false )



Questions
1. What are the objectives of the tests for uniformity of diameter and uniformity of content ?
To ensure each tablet contain the amount of drug substance intended with little variation among tablets within a batch. Then, to indicate the individual contents are within limits set with reference to the average content of the sample. Tablet diameter is a vital quality control test for tablet packaging which affects packaging. Tablet thickness is determined by the diameter of the tablet.



2. State the types of tablets and capsules that must be tested for for uniformity of diameter and uniformity of content.
•           Effervescent Tablet
•           Hard and soft capsule
•           Modified Release Tablet/capsule
•           Enteric-coated tablet/capsule
•           Uncoated tablet


3. Give reasons for the non-compliance to test for uniformity of weight.
It is because of the uneven feeding of granules into the die. In other words, non-uniformity movement of the lower punch will result in the variation in capacity of die space and have to carry out the test. If the ingredients do not mix well at blending stage or do not weight the amount of ingredients accurately, this will also produce those non-compliance.



4.Why does dissolution test suitable to be used for batch to batch quality control?
 It is as an important part of product development and to obtain information on test batches used in bioavailability/bioequivalence studies and pivotal clinical studies to support specifications for quality control.


5.Describe other apparatus that you can use to conduct dissolution test apart from the one found in the laboratory.
In United States Pharmacopeia (USP) General Chapter <711> Dissolution, there are four dissolution apparatuses standardized and specified.They are:
• USP Dissolution Apparatus 1 - Basket (37°C)
• USP Dissolution Apparatus 2 - Paddle (37°C)
• USP Dissolution Apparatus 3 - Reciprocating Cylinder (37°C)
• USP Dissolution Apparatus 4 - Flow-Through Cell (37°C)
USP Dissolution Apparatus 2 is the most widely used apparatus among these four.
The performances of dissolution apparatuses are highly dependent on hydrodynamics due to the nature of dissolution testing. The designs of the dissolution apparatuses and the ways of operating dissolution apparatuses have huge impacts on the hydrodynamics, thus the performances. Hydrodynamic studies in dissolution apparatuses were carried out by researchers over the past few years with both experimental methods and numerical modeling such as Computational Fluid Dynamics(CFD).


EXPERIMENT 4: DOSAGE PERFORMANCE TEST

OBJECTIVE
To determine the dosage performance test.
To determine the time taken by a group of tablets to disintegrate into small particles in the disintegration test.
To measure the amount of active ingredients that have dissolved in a volume of dissolution medium at the prescribed time in the dissolution test.


INTRODUCTION
A process so-called disintegration is the break-up of a tablet as this is the first step before entering dissolution process. An orally administered drug must disintegrate to attain good absorption of its active substance. In disintegration test, the time required by a group of tablets to disintegrate into small particles under standard conditions is necessary to be counted and recorded. This test is used for quality control purpose. Also, the test is used for batch release and trending of lot-to-lot variations during manufacturing of tablets. However, it is not a bioavailability indicator.
Meanwhile, dissolution testing is used to provide information about in vitro drug release and it is for quality control purpose of course, and to predict in vivo drug release profile as well. There are four dissolution apparatuses standardized and specified in United States Pharmacopeia (USP) General Chapter <711> Dissolution. They are USP Dissolution Apparatus 1 - Basket (37°C), USP Dissolution Apparatus 2 - Paddle (37°C) which is the most common method used, USP Dissolution Apparatus 3 - Reciprocating Cylinder (37°C), and USP Dissolution Apparatus 4 - Flow-Through Cell (37°C).

MATERIALS AND APPARATUS
For disintegration test,
6 tablets, Basket-rack assembly, Disc, a beaker (1 litre), water, disintegration machine.
For dissolution test,
900mL of buffer solution, an ibuprofen tablet, UV-visible spectrophotometer, 50mL of standard solution containing 10mg of ibuprofen, dissolution medium, dissolution vessels, syringe with suitable filter, dissolution machine.

PROCEDURES
Disintegration test for sugar-coated tablets
1. The apparatus for the disintegration test according to its operation manual was set up.
2. The temperature of the disintegration medium (medium) was ensured at 37 ± 2°C
3. The time was set to 60 minutes. One tablet was introduced into each tube, the disk was added into each tube and the operation was started.
4. The tablet in each tube was checked at the end of the operation.
5.  Tablets comply with the test if all 6 tablets disintegrate in 60 minutes. If there is any tablet that does not disintegrate, the test using 6 new tablets was repeated but replacing the disintegration medium (water) with 0.1 M hydrochloric acid. Tablets comply with the test if all 6 tablets disintegrate in the acidic medium.
Dissolution test for tablets
1. Each of the dissolution vessel was filled up with the buffer solution to 900 ml mark. The temperature was set to 37°C.
2. The temperature of the dissolution medium was checked.  It was ensured at 37 ± 0.5°C.
3. One Ibuprofen Tablet was placed into each dry basket assembly.
4. The stirring speed was set to 150 rpm. The basket assembly was lowered into position in the vessel and the operation was started.
5. After 30 minutes, 10ml samples of the dissolution medium from each vessel was withdrawn for analysis and the solution was filtered using suitable filter.
Sampling should be done from a point half-way between the surface of the dissolution medium and the top of the rotating basket, and not less than 10nm from the wall of the vessel. Replace the volume of aliquot withdrawn for analysis with an equal volume of same dissolution medium.
6. A standard solution of Ibuprofen was prepared by diluting 10.0mg of ibuprofen reference standard to 50mL with dissolution medium.
7. 2.0mL of sample solution was diluted and 2.0mL of standard solution to 25mL with dissolution medium in separate volumetric flasks.
8. The absorption of both solutions was measured in a 1 cm cell at a wavelength of 221 nm.
9. The percentage amount of ibuprofen dissolved was calculated using the following formula:
Aṯ /Aṣ . W/50 . 2/25 . P . 900 . 25/2 . 100/200
Where Aṯ = absorbance of sample solution
             Aṣ = absorbance of the standard solution
             W = weight of ibuprofen reference standard used
              P = purity of ibuprofen reference standard
10. From the results obtained, the tablets were determined whether comply with the requirements of the British Pharmacopoeia. (Assume Q= 75%)








RESULTS


DISINTEGRATION TEST
All six tablets disintegrated completely in 45 minutes.
No residue except for the remaining of fragments of un-dissolved coating.

DISSOLUTION TEST
Absorbance of sample solution,
0.853
Absorbance of the standard solution,
2.270
Weight of ibuprofen reference standard used, W
10mg
Purity of ibuprofen reference standard, P
0.98

Q = Aṯ /Aṣ . W/50 . 2/25 . P . 900 . 25/2 . 100/200
    = (0.853/2.270) x (10/50) x (2/25) x (0.98) x (900) x (100/200)
    = 33.14%


DISCUSSION

The disintegration test is very straightforward. The individual tablets were held in tubes capped with mesh screens that are agitated by reciprocation in the selected medium, which was water. The disintegration test provides a measure of the amount of time necessary for the dosage form to disintegrate into smaller pieces. It does not involve quantitative measurement of drug concentration.
The sugar coated tablets pass the test if each of the six tablets disintegrate in not more than 60 minutes. From the result obtained, all six tablets disintegrated completely within 45 minutes with no residue except for the remaining of fragments of un-dissolved coating. Thus, the tablets have passed the test.

Disintegration is a state in which no residues except for the remaining of fragments of un-dissolved coating o the screen of the test apparatus. If any residue left, it must consists of soft mass having no evident firm unmoistened core. If the tablets were not able to disintegrate completely, the test need to be repeated using hydrochloric acid as the medium.

Dissolution test measures the amount of active ingredients that have dissolved in a volume of dissolution medium at the prescribed time, using an apparatus specially designed according to the experimental parameters. Q is the specified amount of dissolved active substance, expressed as a percentage of labelled content.

For dissolution test, Q = 33.14% which is less than 75% , thus it does not achieve USP standard as expressed as percentage of labelled content. In this test, the tablet dissolve in the dissolution medium as substituents are present. However, the unevenly distribution of active ingredients in the dissolution medium may result in a low percentage of active ingredients. Hence, this will contribute to an error of the experiment. Also, this condition is related to lower soluble of active ingredients thus more time is required to let them dissolve completely.

            Some precaution has to be taken while conducting both tests. First, in order to obtain a more accurate result, the recommended procedures should be followed accordingly without skipping any steps. Second, avoid parallax error by placing the eyes perpendicularly to the scale. Third, the equipment used in the laboratory should be calibrated at least within 6 to 12 months.

CONCLUSION
  • All the 6 tablets comply with the disintegration test.
  • Ibuprofen does not comply with the dissolution test.


REFERENCES





EXPERIMENT 3: UNIFORMITY OF WEIGHT OF TABLETS AND CAPSULES

OBJECTIVE
To determine the uniformity of dosage and weight of tablets and capsules.


INTRODUCTION
The uniformity of the dosage units can be demonstrated by either content uniformity or mass variation.
Weight variation (WV) test can be done only on certain unit dose as shown in Table 1. Other unit dose will need to undergo content uniformity (CU) test.



In weight variation test, measurement of contents is done by estimation of contents based on weight. Pharmacists often use and misuse this WV test by doing this test on all dosage units. If it is used correctly, this WV test can be used to measure content uniformity (CU). There are some conditions in which the weight difference can determine the percentage difference in the API in the individual dosage units. Hence this WV test can be useful in the quality control of drug production.


MATERIALS AND APPARATUS
Apparatus :Weighing balance, weighing boat
Material : 20 Tablets and 20 capsules

A.                Tablets: Ettracin tablet

PROCEDURES
1. 20 tablets were selected randomly and weighed. The average weight was determined.
2. The tablets were weighed individually and for each tablet, the percentage deviation of its weight from the average weight was determined.
3. The deviation of individual weight from the average weight should not exceed the limits given below.





No.
Individual weight of tablets(g)
Percentage of deviation(%)
1
0.6564
-2.28
2
0.6749
0.48
3
0.6772
0.82
4
0.6617
-1.49
5
0.6749
0.48
6
0.6461
-3.81
7
0.6974
3.83
8
0.6681
-0.54
9
0.6805
1.31
10
0.6930
3.17
11
0.6740
0.34
12
0.6709
-0.12
13
0.6627
-1.34
14
0.6825
1.61
15
0.6824
1.59
16
0.6570
-2.19
17
0.6709
-0.12
18
0.6779
0.92
19
0.6748
0.46
20
0.6504
-3.17



Total weight of 20 tablets =13.4337g
Average weight :  13.4337g / 20

                  =0.6717g
Percentage of deviation =  x 100%

B.CAPSULES: AMPILIN ANTIBIOTIC CAPSULE 250MG
PROCEDURE


1. 20 capsules were selected at random.
2. One capsule was weighed. The capsule was then opened and the contents were removed as completely as possible. The emptied shells were weighed. The net weight of its contents was determined, that is by subtracting the weight of the shells from the weight of the intact capsule.
3. The procedure was repeated with the other 19 capsules.
4. The average net weight was determined from the sum of the individual net weights.
5. The percentage deviation was determined from the average net weight for each capsule. The deviation of individual net weight should not exceed the limits given below.


No
Individual weight of capsules(g)
Weight of emptied shells(g)
Net weight of the contents(g)
Percentage deviation(%)
1
0.3596
0.0640
0.2956
0.24
2
0.3425
0.0636
0.2789
-5.43
3
0.3651
0.0672
0.2979
1.02
4
0.3447
0.0660
0.2787
-5.49
5
0.3633
0.0647
0.2986
1.25
6
0.3454
0.0690
0.2764
-6.27
7
0.3595
0.0624
0.2971
0.74
8
0.3629
0.0627
0.3002
1.80
9
0.3714
0.0626
0.3088
4.71
10
0.3676
0.0623
0.3053
3.53
11
0.3409
0.0625
0.2784
-5.60
12
0.3752
0.0635
0.3117
5.70
13
0.3561
0.0653
0.2908
-1.39
14
0.3637
0.0651
0.2986
1.25
15
0.3629
0.0627
0.3002
1.80
16
0.3582
0.0647
0.2935
-0.47
17
0.3576
0.0645
0.2931
-0.61
18
0.3758
0.0637
0.2941
-0.27
19
0.3766
0.0634
0.3132
6.21
20
0.3524
0.0651
0.2873
-2.58


Total net weight of the content of 20 capsules = 5.8984 g
Average net weight  = 5.8984 g / 20
                                =0.2949 g
DISCUSSION
Since our average weight of the tablets exceed 250mg so the deviation should be±5.0 % for maximum eighteen tablets and only±10.0 % for minimum two tablets. From the results, we can see that all the 20  Ettrocin tablets are having standard deviation of ±5.0%. There is no tablets of having the ±10.0 standard deviation. Hence this indicate that the production of uniform tablets.
If there are more than two tablets of exceeding the ±10.0 standard deviation, this may indicate the ununiformed weights of the tablets and at the same time may indicate the occurrence of errors. The errors might include the presence of tablet fragments or dust on the tablets when weighed. It can also be the systematic error caused by the inaccuracy of the weighing balance. Environmental factors such as vibration of the table or wind from the air-conditioning may also cause the fluctuation in the value presented by the weighing balance.

However, the variation in the weight of the tablets may be explained by the following. Factors such as the flowing properties of the powder, the speed of tableting machine, the pressure used in compression and the type of machines used in tableting may affect the weight of a tablet. However the two most common causes of weight variation are the differences in the bulk densities and particle size distribution during compression.

For capsules, since our average weight is 295 mg, the deviation of individual net weight should not exceed the limits given below:

From the results, all our capsules are having a deviation of ±10%, which means that all capsules have uniform weights. This may indicate the uniformity of the capsules production. At the same time, this uniformity may also be caused by the usage of a good weighing balance. The weighing balance used for measuring the weight of capsule is more accurate as it is a more advanced balance.
If the weight variation in capsule exceeds the limit, this may be due to the defect of the capsule filling machine. The machine may have misalignment of the upper and lower capsule segments or problem in filling the capsule with the target fill weight.


CONCLUSION
The tablets and capsules tested have passed in the test of weight uniformity. This means that both the tablets and capsules tested in this experiment have uniformity in weight production of them.

REFERENCES
1. http://www.pharmainfo.net/files/idownloads/pharmacoeialtestfoDF.pdf
1.Donald K. Lightfoot. (n.d.) Answers To 10 Common Questions About Capsule Filling. Retrieved date. 21st December 2013. From http://capsugel.com/media/library/answers-to-10-common-questions-about-capsule-filling.pdf
2.Dshravani. (2013) Citing Websites. Quality Control Of Capsules. Retrieved date. 21st December 2013. From http://www.pharmainfo.net/quality-control-capsules